{"name":"Jiangxi Kvvit Pharmaceutical Co., Ltd.","slug":"jiangxi-kvvit-pharmaceutical-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"KR230109 cream 0.025%","genericName":"KR230109 cream 0.025%","slug":"kr230109-cream-0-025","indication":"Other","status":"phase_2"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Suraxavir Marboxil","genericName":"Suraxavir Marboxil","slug":"suraxavir-marboxil","indication":"Treatment of HIV-1 infection","status":"phase_3"}]}],"pipeline":[{"name":"KR230109 cream 0.025%","genericName":"KR230109 cream 0.025%","slug":"kr230109-cream-0-025","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Suraxavir Marboxil","genericName":"Suraxavir Marboxil","slug":"suraxavir-marboxil","phase":"phase_3","mechanism":"Suraxavir Marboxil is a prodrug of suraxavir, a nucleotide reverse transcriptase inhibitor.","indications":["Treatment of HIV-1 infection"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":1,"phase_3":1},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}